{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:13:33Z","timestamp":1792174413971,"version":"4.4.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T00:00:00Z","timestamp":1358121600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0052062","type":"journal-article","created":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T23:42:43Z","timestamp":1358206963000},"page":"e52062","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals"],"prefix":"10.1371","volume":"8","author":[{"given":"MyPhuong T.","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian T.","family":"Lobmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene B.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boerwinkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Gums","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,14]]},"reference":[{"key":"ref1","unstructured":"United States Department of Agriculture\/Economic Research Service (2000) U.S. per capita food consumption: Sugars and Sweeteners. USDA."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ajcn\/86.4.899","article-title":"Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease","volume":"86","author":"RJ Johnson","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ajcn\/79.4.537","article-title":"Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity","volume":"79","author":"GA Bray","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/HYPERTENSIONAHA.110.165456","article-title":"Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: international study of macro\/micronutrients and blood pressure","volume":"57","author":"IJ Brown","year":"2011","journal-title":"Hypertension"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2009111111","article-title":"Increased fructose associates with elevated blood pressure","volume":"21","author":"DI Jalal","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.23245","article-title":"Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey","volume":"59","author":"JW Choi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.107.689935","article-title":"Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community","volume":"116","author":"R Dhingra","year":"2007","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(00)04041-1","article-title":"Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis","volume":"357","author":"DS Ludwig","year":"2001","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.292.8.927","article-title":"Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women","volume":"292","author":"MB Schulze","year":"2004","journal-title":"Jama"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archinte.168.14.1487","article-title":"Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women","volume":"168","author":"JR Palmer","year":"2008","journal-title":"Arch Intern Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3945\/ajcn.2008.27140","article-title":"Sweetened beverage consumption and risk of coronary heart disease in women","volume":"89","author":"TT Fung","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1210\/jc.2008-2192","article-title":"Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses","volume":"94","author":"KL Teff","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/oby.2005.136","article-title":"Consuming fructose-sweetened beverages increases body adiposity in mice","volume":"13","author":"H Jurgens","year":"2005","journal-title":"Obes Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1172\/JCI37385","article-title":"Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans","volume":"119","author":"KL Stanhope","year":"2009","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1017\/S0007114508968252","article-title":"Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women","volume":"100","author":"MM Swarbrick","year":"2008","journal-title":"Br J Nutr"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11906-010-0163-x","article-title":"Dietary fructose and hypertension","volume":"13","author":"M Madero","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semnephrol.2004.09.005","article-title":"Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspective","volume":"25","author":"RA Short","year":"2005","journal-title":"Semin Nephrol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.ki.5000391","article-title":"Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease","volume":"69","author":"T Nakagawa","year":"2006","journal-title":"Kidney Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MOL.0b013e3283346ca2","article-title":"Soft drink consumption and obesity: it is all about fructose","volume":"21","author":"GA Bray","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/ijo.2008.204","article-title":"Sugary drinks in the pathogenesis of obesity and cardiovascular diseases","volume":"32 Suppl 6","author":"CM Brown","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1074\/jbc.M808128200","article-title":"Slc2a5 (Glut5) Is Essential for the Absorption of Fructose in the Intestine and Generation of Fructose-induced Hypertension","volume":"284","author":"S Barone","year":"2009","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.nutr.28.061807.155518","article-title":"Sugar absorption in the intestine: the role of GLUT2","volume":"28","author":"GL Kellett","year":"2008","journal-title":"Annu Rev Nutr"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.2337\/diabetes.54.10.3056","article-title":"Apical GLUT2: a major pathway of intestinal sugar absorption","volume":"54","author":"GL Kellett","year":"2005","journal-title":"Diabetes"},{"key":"ref24","unstructured":"Steinmann B, Gitzelman R, Van den Berghe G (2001) Disorders of fructose metabolism. In: Scriver C, Beaudet A, Sly W, editors. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw Hill. pp. 1489\u20131520."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2008.11.018","article-title":"Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study","volume":"157","author":"JA Johnson","year":"2009","journal-title":"Am Heart J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ajh.2007.24","article-title":"Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension","volume":"21","author":"VJ Canzanello","year":"2008","journal-title":"Am J Hypertens"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1523-1755.2002.00200.x","article-title":"Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension","volume":"61","author":"AB Chapman","year":"2002","journal-title":"Kidney Int"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/HYPERTENSIONAHA.107.104273","article-title":"Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic","volume":"52","author":"ST Turner","year":"2008","journal-title":"Hypertension"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e3583","DOI":"10.1371\/journal.pone.0003583","article-title":"Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies","volume":"3","author":"BJ Keating","year":"2008","journal-title":"PLoS ONE"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00439-006-0182-5","article-title":"Efficient selection of tagging single-nucleotide polymorphisms in multiple populations","volume":"120","author":"BN Howie","year":"2006","journal-title":"Hum Genet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"ST Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"ref32","unstructured":"dbSNP BUILD 128.: National Center for Biotechnology Information."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"W621","DOI":"10.1093\/nar\/gkl071","article-title":"PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes","volume":"34","author":"L Conde","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"W635","DOI":"10.1093\/nar\/gkl236","article-title":"FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization","volume":"34","author":"HY Yuan","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/biot.200600213","article-title":"Whole genome genotyping technologies on the BeadArray platform","volume":"2","author":"FJ Steemers","year":"2007","journal-title":"Biotechnol J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1152\/physiolgenomics.00061.2009","article-title":"Kininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA study","volume":"39","author":"M Barbalic","year":"2009","journal-title":"Physiol Genomics"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"F Faul","year":"2009","journal-title":"Behav Res Methods"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"F Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0026-0495(97)90192-X","article-title":"Effect of ethanol and fructose on plasma uridine and purine bases","volume":"46","author":"T Yamamoto","year":"1997","journal-title":"Metabolism"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/ard.33.3.276","article-title":"Effect of oral fructose on urate production","volume":"33","author":"BT Emmerson","year":"1974","journal-title":"Ann Rheum Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2458-4-9","article-title":"Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country","volume":"4","author":"D Conen","year":"2004","journal-title":"BMC Public Health"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"DJ Gordon","year":"1989","journal-title":"Circulation"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1681\/ASN.2007101075","article-title":"Uric acid and incident kidney disease in the community","volume":"19","author":"DE Weiner","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.1142447","article-title":"A common allele on chromosome 9 associated with coronary heart disease","volume":"316","author":"R McPherson","year":"2007","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature06258","article-title":"A second generation human haplotype map of over 3.1 million SNPs","volume":"449","author":"KA Frazer","year":"2007","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1371\/journal.pbio.0000020","article-title":"Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action","volume":"1","author":"I Barroso","year":"2003","journal-title":"PLoS Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1515\/jpem-2008-210612","article-title":"Hyperglycemia and hypoinsulinemia in patients with Fanconi-Bickel syndrome","volume":"21","author":"D Taha","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ng1197-324","article-title":"Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome","volume":"17","author":"R Santer","year":"1997","journal-title":"Nat Genet"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"GF Lewis","year":"2005","journal-title":"Circ Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/diabetes.54.7.2256","article-title":"Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study","volume":"54","author":"O Laukkanen","year":"2005","journal-title":"Diabetes"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group","volume":"341","author":"HB Rubins","year":"1999","journal-title":"N Engl J Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1050-1738(01)00084-6","article-title":"Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance","volume":"11","author":"K Adeli","year":"2001","journal-title":"Trends Cardiovasc Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1172\/JCI30163","article-title":"Molecular regulation of HDL metabolism and function: implications for novel therapies","volume":"116","author":"DJ Rader","year":"2006","journal-title":"J Clin Invest"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/archinte.1990.00040031653012","article-title":"Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines","volume":"150","author":"L Bookstein","year":"1990","journal-title":"Arch Intern Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajhg.2007.11.001","article-title":"Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia","volume":"82","author":"C Wallace","year":"2008","journal-title":"Am J Hum Genet"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1371\/journal.pgen.0030194","article-title":"The GLUT9 Gene Is Associated with Serum Uric Acid Levels in Sardinia and Chianti Cohorts","volume":"3","author":"S Li","year":"2007","journal-title":"PLoS Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0052062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T17:08:25Z","timestamp":1745946505000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0052062"}},"subtitle":[],"editor":[{"given":"Ali J.","family":"Marian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,14]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0052062","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,14]]}}}